´ç´¢º´ ´Ù½Ã ¹è¿ì±â
- ÀúÀÚ(±Û)¿À½ÂÁØ ¿Ü
- ÃâÆÇ»ç´ëÇÑÀÇÇÐ
- ¹ßÇàÀÏ2021³â 01¿ù 10ÀÏ
ȯÀÚ ¸ÂÃãÇü ´ë»çÁúȯ °ü¸® ¼±µµ ±ÇÀ§ÀÚ
´ç´¢º´, °©»ó¼±Áúȯ, ºñ¸¸ Ä¡·áÀÇ ±ÇÀ§ÀÚ·Î ¼Õ²ÅÈ÷´Â ¿À½ÂÁØ ±³¼ö´Â ȯÀÚ ¸ÂÃãÇü Ä¡·á °èȹ ¼ö¸³¿¡ Ź¿ùÇÑ ¼º°ú¸¦ º¸À̰í ÀÖ´Ù. ÃֽŠġ·á ±â¹ý°ú ¾à¹°À» Ȱ¿ëÇÏ¿© È¿°úÀûÀÎ Áúȯ °ü¸®¸¦ µ½°í ÀÖÀ¸¸ç, Áö¼ÓÀûÀÎ ¿¬±¸¸¦ ÅëÇØ »õ·Î¿î Ä¡·á¹ý °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ´Ù. ´ÙÇÐÁ¦Àû Á¢±ÙÀ» ÅëÇØ Á¾ÇÕÀûÀÎ ´ë»çÁúȯ °ü¸® ½Ã½ºÅÛÀ» ±¸ÃàÇÏ¿© ȯÀÚµéÀÇ »îÀÇ Áú Çâ»ó¿¡ ±â¿©Çϰí ÀÖ´Ù.
| Á¦ ¸ñ | KNDP 2Çü ´ç´¢º´ ȯÀÚÀÇ Àν¶¸° Ä¡·á¿Í Ç÷´ç°ü¸® Áöħ | ||
|---|---|---|---|
| ÃâÆÇ»ç | ¹ßÇàÀÏ | 2011³â 11¿ù | |
| Á¦ ¸ñ | 2011³â ³»ºÐºñ´ë»ç³»°ú ÀÓ»ó ½Ç½À | ||
|---|---|---|---|
| ÃâÆÇ»ç | ¹ßÇàÀÏ | 2011³â 02¿ù | |
| Á¦ ¸ñ | Diagnosis and treatment of growth hormone deficiency: A position statement from Korean endocrine society and Korean society of pediatric endocrinology | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2020 | ¹ßÇ¥Áö | |
| Á¦ ¸ñ | Medical treatment with somatostatin analogues in acromegaly: Position statement | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2019 | ¹ßÇ¥Áö | |
| Á¦ ¸ñ | Analysis of diabetes quality assessment findings and future directions for the appropriate management of diabetes in Korea | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2019 | ¹ßÇ¥Áö | |
| Á¦ ¸ñ | Tetrabromobisphenol A Promotes the Osteoclastogenesis of RAW264.7 Cells Induced by Receptor Activator of NF-kappa B Ligand In Vitro | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2019 | ¹ßÇ¥Áö | |
| Á¦ ¸ñ | Cardio-ankle vascular index as a surrogate marker of early atherosclerotic cardiovascular disease in Koreans with type 2 diabetes mellitus | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2018 | ¹ßÇ¥Áö | |
| Á¦ ¸ñ | Tetrabromobisphenol A induces cellular damages in pancreatic ¥â-cells in vitro | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2017 | ¹ßÇ¥Áö | |
| Á¦ ¸ñ | Exposure to tetrabromobisphenol A induces cellular dysfunction in osteoblastic MC3T3-E1 cells | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2017 | ¹ßÇ¥Áö | |

°æÈñ´ëÇб³º´¿øÀº ȯÀÚ Áß½ÉÀÇ ÀÇ·á ¼ºñ½º¸¦ Á¦°øÇϸç, ±¹³» ÀÇ·á°è¸¦ ¼±µµÇÏ´Â »ó±ÞÁ¾ÇÕº´¿øÀÔ´Ï´Ù. ÃֽŠÀÇ·á ±â¼ú°ú Àåºñ¸¦ Ȱ¿ëÇÏ¿© ȯÀڵ鿡°Ô ÃÖ»óÀÇ Ä¡·á¸¦ Á¦°øÇÕ´Ï´Ù. ƯÈ÷ ÁßÁõÁúȯ Ä¡·á ¹× ¿¬±¸¿¡ °Á¡À» º¸À̸ç, ´ÙÇÐÁ¦ ÇùÁø ½Ã½ºÅÛÀ» ÅëÇØ ȯÀÚÀÇ °Ç°À» ÃÖ¿ì¼±À¸·Î »ý°¢ÇÕ´Ï´Ù. °æÈñ´ëÇб³º´¿øÀº ȯÀÚµéÀÇ ½Å·Ú¿Í ¸¸Á·µµ¸¦ ³ôÀÌ´Â µ¥ ÁÖ·ÂÇϸç, Áö¼ÓÀûÀ¸·Î ÀÇ·á ǰÁú Çâ»ó°ú ¿¬±¸ °³¹ß¿¡ Èû¾²°í ÀÖ½À´Ï´Ù.
¼¿ïƯº°½Ã µ¿´ë¹®±¸ °æÈñ´ë·Î 23 °æÈñ´ëÇб³º´¿ø